SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
BioMimetic Therapeutics, Inc. Strengthens its Agreement with Novartis Vaccines & Diagnostics, Inc. for Exclusive Supply of rhPDGF-BB